Li P et al. [79] also investigated tumor visibility on mpMRI and its underlying biology, identifying four genes (PHYHD1, CENPF, ALDH2, GDF15) that predicted MRI visibility (AUC 0.86) and progression-free survival (PFS). The gene discussed is PHYHD1; the disease is neoplasm.